Market Research Blog – Page 13288 – New Product Development

Molecular Imaging Market will expand at an impressive CAGR of around 11.3% from 2021 to 2031

Molecular imaging is an emerging diagnostic technology that allows visualization, differentiation, and quantify various biological processes occurring inside a living organism at the molecular and cellular level. The global molecular imaging market is estimated to be valued approximately at US$ 4 Bn in 2021, finds Future Market Insights (FMI) in a study.

Molecular imaging targets molecular pathways and mechanisms associated with a particular disease present inside a living body. It enables to study of the molecular abnormalities taking place inside the body to carry out early detection of disease and to optimize medications aiming for disease-related molecular targets. Nuclear medicine plays a vital role in conducting a molecular imaging process and can be broadly used for the treatment of distinct cancer and related diseases.

Clinical molecular imaging is trending towards hybrid modalities such as PET-CT, SPECT, or PET-MR that provide high-resolution anatomical imaging. PET-CT is anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 16.3% during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-724

Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumor genome, as well as monitoring tumor emergence during disease. Molecular imaging provides the ability to accurately evaluate biological responses to the treatment of individual patients over time, opening the door to personalized medical techniques directed by molecular imaging reporters.

Key Takeaways from Molecular Imaging Market Study

Molecular imaging market will register accelerating demand, enabling a y-o-y growth of nearly 11% in 2021
Backed by presence of a state-of-the-art healthcare infrastructure, the U.S. accounts for nearly 65% sales in North America
Driven by rising cases of cancer, the U.K. market will exhibit above 14% y-o-y growth in 2021
Government initiatives aimed at offering advanced medical care will enable growth in Germany and France
The market in China is expected to surge at a CAGR of over 10% from 2021 to 2031

Molecular Imaging Needs Rising In Response to Increasing Cancer Cases

According to the World Health Organization (WHO) in 2020, breast cancer emerged as the most common type of cancer, affecting 2.2 million people around the world. Lung cancer has been the leading cause of death with over 1.7 Mn of total deaths in 2020. North America has the highest incidence rate of cancer followed by East Asia. This rise in the cancer population is leading to a rise in the demand for diagnostic imaging, thereby catalyzing the demand for molecular imaging.

Who is Winning?

Key players in the molecular imaging market are keenly focusing on carrying out strategic activities such as acquisitions, collaborations, and mergers, product launch, global expansion to create a strong position in the market is leading to vigorous developments which are helping the market to grow at a considerable rate.

Some of the key players are Key market players covered by Future Market Insights in the report are is Hermes Medical Solutions, Bruker Corporation, GE Company, Fujifilm Holdings Corp., Koninklijke Philips N.V., Siemens AG, Toshiba Medical System Corp., Mirada Medical Limited, Carestream Health, Inc., Esaote SpA, Positron Corporation, Medisco Ltd., Hitachi Medical Corp., MIM Software Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-724

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights,
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Generic Injectable Market to rise at 11.6 % CAGR through the end of the forecast period in 2031

Generic injectable are cost friendly and display faster treatment efficacy in a safe and effective manner for chronic ailments including cancer, diabetes, and cardiovascular diseases. According to Future Market Insights (FMI), the demand for generic injectables is expected to rise considerably, enabling the market to surpass US$ 85.0 Bn by the end of 2021. In coming years, the rising cases of chronic disease will support the expansion of the market.

Generic injectable substitutes branded products offers various advantages to patient in terms of prices without affecting treatments. Cancer treatments are often fraught with drug shortages with supplies in countries falling short owing to low access to payers and reimbursement. Increasing technological advancements in the production of generic injectables for the treatment of chronic diseases have led to the higher adoption of generic injectables in clinical practices associated with improved outcomes.

Increasing investments in research and development projects and favorable regulatory policies are some factors enabling growth in the generic injectable market. Also, growth in healthcare spending and medical tourism is supporting growth in market. As of 2020, the global healthcare industry is the second largest industry in terms of R&D spending, ranked after computing and electronics. Moreover, the rapidly expanding healthcare R&D expenditure is expected to overtake the expenditure of the computing and electronics industry in 2020. The healthcare industry spent approximately US$ 48 billion on R&D in 2015, which rose to around US$ 159.0 billion during 2020.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6051

The impact of the COVID-19 pandemic on the generic injectable market has been marginal. The generic Injectable market is expected to experience short-term negative growth owing to a sharp reduction in research activities and reduced resources available to meet the unprecedented requirements of the industry.

As a result of the continuing spread of COVID-19, various service providers are focusing on novel approaches to the treat pneumonia associated with COVID-19 using generic injectables. Thus, scientists are focusing on injections effective for covid-19 treatment. This provides niche opportunities for generic injectable market to grow.

Key Takeaways from Generic Injectable Services Market Study

Despite restricted growth amid COVID-19, the demand for generic injectable is expected to rise at nearly 5% through 2021
Sales of monoclonal antibody injectables will account for nearly One-fourth of the market, driven by increasing prevalence of autoimmune diseases
Increasing focus on early diagnosis will enable France to register 12.6% Y-o-Y growth in 2021
Germany and France are expected to exhibit increasing demand to tackle concerns pertaining to rising incidence of cancer
United States will account for more than 29% of the global market through the end of 2031 owing to R&D investments
The U.K. will exhibit a double-digit y-o-y growth at above 11% in 2021, as demand from hospital pharmacies continues to grow

Increase in Funding For Research Activities Offers Growth Opportunities

Leading manufacturers in the generic injectable market are strengthening their market position through collaboration with various other organization. Governments in developed and developing countries are actively taking initiatives to encourage research activities for the development of generic injectable offerings.

Who is winning?

The global market is set to expand in the forecast period, due to the rising prevalence of chronic diseases globally and the adoption of generic injectables. Leading organizations within the market are set to focus on research and development to offer early and precise diagnosis of the ailment, besides offering effective patient care.

Leading manufacturers in the global generic injectable market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co. Inc., Mylan N.V., Cipla Inc., Dr.Reddy’s Laboratories Ltd., Samsung Biologics, Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, and Baxter International Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6051

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Nasal Spray Market be valued at more than US$ 3.21 Billion by 2030-end

Future Market Insights (FMI) has forecast positive outlook for the nasal spray market in a recent study. The rising cases of allergic rhinitis and the demand for better accuracy in drug delivery are identified as chief growth drivers. Growth is expected to remain bullish as various countries showcase high healthcare spending.

According to a study by the Research and Development (RAND) Review blog published in 2017, nearly 60% of Americans have at least one chronic health condition, which often results in accelerating healthcare spending each year. With the incidence of chronic ailments and resultant spending on healthcare projected to spur, nasal sprays market will have positive growth on cards.

As per the report, the market’s overall valuation is likely to surpass US$ 15 Bn by 2021. Growth will continue at a positive rate, thanks to recent approvals to nasal migraine and hormonal therapies.

Among products available, nasal steroid spray will prove exceptionally lucrative, accounting for over 42% of sales in the market. Besides their improving availability, potential to offer relief from nasal allergies and hay fever will drive growth in the category

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13112

Key Takeaways from Nasal Spray Market Study

Rising at above 6% CAGR between 2021 and 2031, nasal sprays market will report consistent surge in demand
The market in the U.S. is projected to a fast-growing one, accounting for more than 90% share in the North America market
Government spending on healthcare has created a conducive environment for growth in the U.K.
Germany will emerge as a leading market for nasal sprays sales in Europe backed by increasing healthcare spending and presence of leading manufacturers
Focus on health and wellness will continue rising in Japan and South Korea, driving nasal spray sales in East Asia

Government Initiatives toward Nasal Spray Consumption

Governmental support for ongoing clinical research, consumption of Nasal Spray, and restricting misuse have favoured growth in demand for Nasal Spray. For instance, there has been a call for rise in production capacity of budesonide nasal spray which shortens COVID19 recovery time.

Since, nasal sprays are also used for depression patients, the market is likely to grow highly.

Who is Winning?

Nasal spray manufacturers with patented drugs are successfully allocating their distribution rights to local companies that are operational in the pain management business. This strategy provides momentum to the growth of these companies’ business, owing to strong demand for generic drugs.

For instance, In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13112

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Pharmaceutical Lipids Market demand to grow at 10.7% CAGR through 2021-2031

Global pharmaceutical lipids market is projected to rise at a considerable pace between 2021 and 2031, finds Future Market Insights in an in-depth study. Growth registered in the market is attributable to increasing cases of cholesterol abnormalities and lipid associated disorders. Lipids are generally utilized in industries such as cosmetics and personal care, beverage and food, and pharmaceutical. Rising urbanization that has led to remarkable lifestyle changes have been influencing trends in the cosmetics and personal care industry. Expansion of the sector, which also is a key end user, will fuel sales of pharmaceutical lipids.

Social media and digitalization are greatly influencing the sales of beauty care products. Coupled with this, increasing demand for the effective and fast-acting medications combined with improvement of advance drug manufacturing facilities have been driving the pharmaceutical lipids market. Also, the rising incidence of cancer, neurological diseases, cardiovascular diseases, and other chronic diseases are expected to fuel the demand for pharmaceutical lipids

According to the report, demand in the triglycerides segment within the market will be considerably high. It is expected to account for nearly 44% of the market in 2021.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10983

Key Takeaways from Pharmaceutical Lipids Market Study

The global pharmaceutical lipids market will rise at 5.2% CAGR between 2021 and 2031
The U.S. is the most lucrative market in the global pharmaceutical lipids market and is expected to grow with a CAGR of 5.5% between 2021-2031
The demand for triglycerides will continue rising in the U.K., driving pharmaceutical lipids sales
Germany will lead the Europe market; France too will continue exhibiting high demand
China will account for maximum sales in East Asia

Who is Winning?

Companies operating in the market are looking for strengthening their footprint via strategic tie-ups and acquisitions. The pattern is primarily seen across companies operating in Europe and North America.

Key Participant Insights

The pharmaceutical lipids market is considered to be an exceptionally competitive market. The strategies involve growing new lipid-based formulations. Research is being led in regards to designing combination drugs (proteins and lipids) for projection with respect to dyslipidemia and furthermore cardiovascular disorders. This pattern is relied upon to make a significant rise in the estimated time frame. The key market players covered by FMI include ABITEC Corporation (ABF Ingredients), NOF (Nippon Oil & Fats) Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company and Evonik Industries AG.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10983

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Light Therapy Market is anticipated to experience credible gains through 2021-2031

ESOMAR certified market research company Future Market Insights (FMI) global light therapy market is likely to surpass US$ 1 billion in the short-run, expanding at a moderate CAGR in that time period. Long-term prospects appears largely optimistic, with credible opportunities expected to present themselves with respect to addressing acute depression problems.

As per FMI’s report, growth prospects are likely to emerge across skin and insomnia treatment domains as well. With at least one to three out of ten people experiencing disrupted sleep cycles, patients are seeking effective therapeutic approaches, thereby widening growth prospects. Furthermore, skin ailments contribute to almost 2% of the global burden of disorders.

Manufacturers are primarily emphasizing on introducing portable and lightweight handheld light therapy devices amid the rising demand for flexible therapeutic solutions. For instance, the LightStim For Wrinkles is an award-winning FDA-cleared red light therapy device for skincare, deploying a patented multi-wave technology based on advanced LED technology from NASA. Likewise, the iRestore Laser Hair Growth System for treating androgenic alopecia deploys a 650 mm wavelength red light which is clinically proven to enhance hair growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1160

Key Takeaways from FMI’s Light Therapy Market Study

By product, handheld light therapy devices for skin treatment are likely to enjoy highest demand
By light type, demand for red light therapy is expected to reach new heights, characterized by increasing numbers of clinical trials
By end-user, dermatological centers are expected to be primary light therapy treatment centers in forthcoming years
High seasonal affective disorder (SAD) incidence fueling light therapy treatment in the US
UK to attract high investments, characterized by the presence of prominent phototherapy light manufacturers
Germany to generate lucrative growth prospects amid extensive applications across the photodynamic treatment (PDT) segment
Surging dermatological problems to widen natural treatment approaches scope in India, widening prospects for light therapy

Competitive Landscape

Koninklijke Philips N.V., Verilux Inc., Northern Light Technology, Sphere Gadget Technologies, Zepter International, PhotoMedex Inc., Luminette, Klarstein, Lumie and Aura Daylight are some prominent light therapy market players profiled by FMI’s report on the landscape.

Offering new products based on the latest technology is the primary strategy deployed by a majority of the aforementioned market players. For instance, Klarstein offers its 3MC light therapy sunlight SAD disorder lamp for medical purposes. This product is especially suitable for treating for treating seasonal affective disorder by deploying a mid-day simulating spectrum.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1160

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Skincare Market to grow at a healthy CAGR of 8.1% through forecast period of 2021-2031

Increase In awareness regarding advanced skincare products and rising prevalence of chronic diseases are expected to drive skincare market. According to a study by Future Market Insights (FMI), the global skincare market is forecast to reach a valuation of US$ 8,823.4 Mn in 2021.

Skincare products such as skin cleansers, hand sanitizer, skin conditioners, and surgical scrubs are increasingly used to maintain skin hygiene and to prevent the spread of infections. The rising prevalence of chronic diseases and increase in demand for hand sanitizers amid COVID-19 pandemic is expected to boost the growth of the skincare market.

Moreover, increasing incidence of hospital-acquired diseases such as surgical site infection (SSI) is creating opportunities for growth. Sales will surge further as a result of the increasing awareness about advanced skincare products. Social media & innovative online campaigns aimed at creating awareness are therefore reshaping the skincare market.

Increasing market consolidation activities, adoption of strategic agreements among the leading manufacturers and increasing research activities aimed at launching effective products are some of the factors enabling growth. Some of the leading players are aiming to strengthen their product portfolio by launching a various online campaign. For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil launched an innovative digital campaign to connect with millions of consumers experiencing skin sensitivity.with the market expected to exhibit a CAGR of 8.1% during the forecast period (2021-2031)

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13122

Key Takeaways from Skincare Market Study

Skincare market is expected to rise at 8.1% CAGR between 2021 and 2031
High willingness among consumers to spend on personal health and hygiene will drive growth in the U.S., which will account for over 85% of sales in North America by 2031
The U.K. will remain a key market for skincare products within Europe. Rising demand from various hospitals, healthcare, and critical care centers will continue supporting growth
Expansion of the healthcare sector will push growth in Germany, which will account for maximum skincare products sales within Europe’s healthcare sector
Strong growth is likely in China, as consumers increasingly focus on hygiene and sanitization to prevent the risk of infection

Who is Winning?

The leading manufacturers are focusing on research and development to develop effective and compatible skincare products that can meet the end-use demand. The current pandemic outbreaks and the growing demand for hand sanitizing product have led manufacturers to ramp up their research efforts to expand their product portfolio.

Besides this, several key players are focusing on market consolidation activities such as a merger, acquisition, supply distribution partnerships, and launching new products. This is leading to high competitiveness in the market. Key manufacturers are also keen to expand the market footprint.

Some of the market players covered by FMI include are 3M Company, Cardinal Health, Inc., Ecolab, Whiteley Corporation, Reckitt Benckiser Group PLC, Carrollclean, Johnson & Johnson Consumer Inc., Galderma Laboratories, L.P., PDI, Inc., Betco Corporation, Pal International, PSK Pharma Pvt. Ltd., Metrex Research, LLC., Gojo Industries, Inc., Unilever, Steris Plc, Procter & Gamble and among others consolidating their positions through mergers, acquisitions and new product launches.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13122

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Sleep Apnea Implants Market to grow at a 17.3% CAGR through 2021-2031

Rising inclination towards non-invasive procedures and increasing focus on the advancement of sleep apnea devices have created lucrative opportunities for the expansion of the sleep apnea implants market. As per a study by Future Market Insights, application of sleep apnea implants ranges from snoring to sleep-deprived complications. Additionally, an increase in the number of obese and geriatric people is associated with a rise in the prevalence of sleep disorders.

Sedentary and unhealthy lifestyles may lead to heart diseases, diabetes and other diseases, which may lead to sleep disorders. Moreover, the rising global burden of obstructive sleep apnea (OSA) or central sleep apnea that may increase the risk of fatal accidents and the growing number of sleep apnea therapies are expected to boost the sleep apnea market growth during the forecast period.

Sleep deprivation is also associated with lost productivity. In a study by RAND Corporation, it is stated that in the U.S. there are around 1.2 million lost workdays due to sleep deprivation per year and as a result, the economic impact of productivity losses and higher mortality rates will account for over US$ 400 billion, or 2 per cent of the GDP.

The global sleep apnea implants market was valued at US$ 188.3 Mn in 2021. Based on product type, hypoglossal neurostimulation devices are expected to gain popularity in the sleep apnea implants market, accounting for 80% of the revenue in 2020.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8698

Key Takeaways of Sleep Apnea Implants Market Study

Driven by rising prevalence of sleep disorders, the sleep apnea implants market will exhibit 17.3% CAGR between 2021 and 2031
Rising concerns pertaining to sleep deprivation has fuelled demand in the U.S., which accounts for the leading share in North America
The U.K. will remain a key market for sleep apnea implants on the back of rising awareness about the condition and willingness to spend on treatment
As per the Journal of Thoracic Disease, population based studies have indicated that nearly 50 million patients in China suffer from OSA. With focus on providing advanced healthcare rising, the demand for sleep apnea implants will rise in China
Expansion of the healthcare sector and rising demand from hospitals will continue supporting growth in India

Who is Winning?

FDA approvals for sleep apnea implants are aiding the adoption of advanced sleep apnea products. Numerous manufacturers are focusing on the research and development area to innovate advanced products with high safety and efficacy.

In May 2019, Siesta Medical, Inc. (Private), announced FDA clearance for expanded indications for its Encore™ Tongue Suspension System for the treatment of obstructive sleep apnea.

The sleep apnea implants market is considered diverse due to the presence of various local and international players in the competitive market. Competing to gain a large market share, the players continue to rely upon acquisitions, investments and alliances to provide access to new technologies in both new and existing markets.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8698

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Herbal Medicinal Products Market is expected grow at a CAGR of 7.7 % for 2021 – 2031

Government initiatives undertaken around the world, especially in the West to encourage the use of herbal medicine has resulted in the development of mass distribution networks, increasing prescription of homeopathic medications, and demand for Ayurveda treatments.

According to a recent study by Future Market Insights (FMI), these factors have proven crucial at enabling growth in the herbal medicinal market. Sales of herbal medicines are expected to top US$ 171.62 Bn in 2021, at a CAGR of 7.7% during the forecast period (2021-2031).

Soaring concerns pertaining to adverse effects of allopathic medicines has been causing gradual shift of preference in favor of traditional herbal medicines. These medicines are often used for treatment of ailments including neurological diseases, cough, cold & flu, sexual problems, feminine problems, and metabolic diseases. Herbal remedies are used to maintain health and systemic balance, of body functions without sedation and side effects.

In 2015, La Political de Attention Integral a la Saluda Indigene de FUNASA of Brazil promoted traditional systems of health of indigenous communities. Similarly, the government has recognized homeopathic medicines as a medical specialty and included it in the National Health System. Brazil is currently home to around 12,000 homeopathic physicians and 300 homeopathic pharmacists.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2722

As per the World Health Organization (WHO), around 60% of the world’s population is reliant on herbal medicines for primary health care needs. In developing countries, this number accounts for up to 80%. Around 75% of such sales are made through direct user-pharmacy contacts. The growing trend of online pharmacies and mail-on-order purchases drives the demand for self-medication.

The global geriatric population is rapidly expanding with higher life expectancy rates. According to the World Bank, in 1990, the average mortality among geriatric world population was around 6 %, which increased to 9.5% in 2020. The prevalence of chronic diseases associated with an aging population portrays the need for effective medications.

Key Takeaways from Herbal Medicinal Products Market Study

Demand for Chinese medicines is expected to grow at 8.2% CAGR through 2031, owing to investments into promotion of traditional Chinese medicine.
Retail pharmacies are projected to capture over 23% of the global market by 2031. This is attributed to availability of consumer health products.
Europe is the largest revenue-generating region for herbal medicinal products, with Germany accounting for nearly 18% of the regional market in 2031.
China holds the leading position in East Asia, and is expected to account for over 49% of the market in 2031.
South Asia is the third most lucrative market with India accounting for over 74% of the share in 2031.

Who is Winning?

Some of the leading manufacturers of herbal medicinal products are focusing on product launch strategies for global expansion objectives, thereby, enhancing their market presence.

The key market players covered by FMI include Blackmores Limited, Sanofi-Aventis Healthcare PTY Ltd., Arkopharma SA, Nutraceutical Corporation, STADA Arzneimittel AG, Himalaya Global Holdings Ltd, Integria Healthcare, Boiron Group, Young Living Essential Oils, and Mountain Rose Herbs.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2722

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Urinary Bag Market will rise at a CAGR of 4.4% CAGR between 2021 and 2031

According to a revised report published by Future Market Insight (FMI), the global urinary bag market was valued at US$ 1.74 Bn in 2021, and is predicted to expand at a CAGR of 4% over the forecast period (2021–2031).

Urinary bags are primarily used to help in the collection of urine from the bladder, which is attached to the other end of a catheter. These are used by patients suffering from urinary incontinence, retention issues, or spinal cord injuries that made a urinary catheter necessary. Urinary bags are available in leg bag, belly bag, large capacity bag, and drainage bag variants.

Leg bags are small sized products designed to be worn under clothes. It is designed for active people with urinary incontinence problems. The product is worn around the waist. Availability in various designs to suit specific requirement of patients has been creating growth opportunities for the market.

Consolidation activities such as collaborations, partnerships, patent transfers, and increasing research and development activities, are distinctive trends influencing competition in the urinary bags market. The growing prevalence of urinary incontinence and gynaecology surgeries is a major factor leading to an increase in the demand for urinary bags, globally.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13236

Key Takeaways from Urinary Bag Market Study

Drainage bags are expected to hold dominance with a market share of more than 49% in 2021. Rising applications in hospitals among geriatrics and post-surgery patients will aid expansion of sales within this category.
Urinary bags with a 1000 ml capacity are expected to account for 33% the global market share by 2031.
Hospitals are expected to account for 38% of the market share in 2031 which can be broadly attributed to the higher footfall of patients they register on a daily basis.
The U.S. has emerged as a leading market, accounting for over 90% of sales registered in North America.
Germany is a leading market for urinary bags and is forecast to account for over 33% of sales in Europe in 2021.
The market in Japan is projected to emerge dominant East Asia, driven by the presence of a mature healthcare sector and easier access to new technologies.

Government Initiatives Towards Urinary Bag Usage

Integration of advanced features and technology that aid in patient care has strengthened support and services to patients. The COVID-19 crisis drastically increased the demand for urinary bags owing to the massive impact of the disease on the global healthcare system.

This has generated massive growth potential for the urinary bag market for treatments and patient-care. Governmental support for ongoing clinical research and the usage of urinary bags in hospitalization processes, have created a conductive environment for market players.

Who is Winning?

Leading players in the moderately fragmented urinary bags market are focused on investments into research and development for product development objectives. In addition to portfolio expansion, manufacturers are also seeking to consolidate their position with strategic geographical expansion endeavours.

Some of the leading players in the urinary bags market include but are not limited to C.R. Bard Inc., Medline Industries, Inc., Cardinal Health, Inc., Hollister Incorporated, Teleflex Incorporated, Cook Medical, Moore Medical Llc., Mckesson Medical-Surgical Inc., Arcus Medical Llc., Urocare, Covidien, Coloplast A/S, B. Braun, Romsons, Poly Medicure Limited, G.Surgiwear Ltd., Kiefel Medical, Jolfamar, UROMED, Wujiang Evergreen Ex/Im Co. Ltd., Leboo Healthcare Products Limited.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13236

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

U.S. Digital Ovulation Test Kits Market will rise at 9.6% CAGR between 2021 and 2031

Digital ovulation tests help women to maximize the chances of conceiving naturally by identifying the two most fertile days of their menstrual cycle by measuring the changes in the level of luteinizing hormone (LH), which is important to fertility parameters. According to Future Market Insights (FMI) the U.S. digital ovulation test kits market is estimated to be US$ 80 Mn in 2021, and is expected to grow at a market CAGR of 9.6% during the forecast period (2021-2031)

Some of the digital devices available in the market have advanced features such as connectivity to Bluetooth or smart countdown. Clearblue, First Response and E.P.T. are some of the most popular digital ovulation test kits brands available in the U.S. market.

Increasing purchasing power and growing consumer awareness about women’s health are the two factors expected to drive the growth of the digital ovulation test kits market in the U.S. Various states in the country are focusing on improving women health through various awareness and healthcare programs.

For instance, the American pregnancy association along with its education partner Fairhaven Health LLC guides ovulation testing to couples trying to get pregnant. This is anticipated to boost the growth of the digital ovulation test kit market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13241

Rising first-time pregnancy demographics and decreasing fertility rates, along with rising levels of disposable income and growing advancements in ovulation testing are some of the major factors driving the growth of the digital ovulation test kit market in the U.S.

The COVID-19 pandemic has significantly affected the sale of digital ovulation test kits. The nationwide lockdown and disrupted supply chains have limited the availability of these products. The pandemic in the first few months of 2020 has negatively impacted the digital ovulation test kits market.

Key Takeaways from the U.S. Digital Ovulation Test Kits Market Study

Branded test kits are expected to dominate the U.S. digital ovulation test kits market, rising at a CAGR of around 9.3%.
Institutional sales are expected to witness significant growth with easier access to patients driving a CAGR of around 8.8%.
Home based use of digital ovulation test kits to gain traction owing to lower stress for use through menstrual cycles.
Relatively higher costs to potentially limit sales of digital variants of ovulation test kits in the country.

Who is Winning?

The U.S. market is set to expand strongly owing to the rising prevalence of fertility disorders and the adoption of digital ovulation test kits. Furthermore, the advancements in digital ovulation test kits are expected to boost market demand.

Key market players covered by FMI include Church & Dwight Co. Inc., Swiss Precision Diagnostics GmbH, Sugentech Inc., Gregory Pharmaceutical Holdings, Inc., iXensor Co. Ltd, Samplytics Technologies Private Limited, Bio-AMD, and others consolidating their positions through mergers, acquisitions and new product launches.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13241

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us: